| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |